FOSL2 and breast cancer: FOSL2 knockdown significantly weakened the inhibitory effect of ZN444B on breast cancer cell growth and metastasis in vitro, resulting in breast cancer cells being insensitive to ZN444B treatment (Fig. 4H-J).